Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types. - Chen HC; Mueller N; Stott K; Kapeni C; Rivers E; Sauer CM; Beke F; Walsh SJ; Ashman N; O'Brien L; Rafati Fard A; Ghodsinia A; et al. (EMBO molecular medicine, 2024)